Research and Breakthroughs

A recent study led by Principal Investigator Michael Goran, PhD, and Rachel Schenker, MD, a Fellow in the CHLA Liver Transplant Program, has found a novel combination of plasma-based biomarkers that

A Children’s Hospital Los Angeles study has found that a virus that infects a common bacteria may lead to accelerated loss of lung function in individuals with cystic fibrosis (CF). The study

Effects on children’s brains from premature birth are more drastic the earlier infants are born and can last until adulthood

CHLA faculty will share new research on pediatric blood cancers and diseases at the American Society of Hematology Annual Meeting in San Diego.

Physicians can use late gadolinium enhancement technique to identify high-risk hypertrophic cardiomyopathy patients.

More precise definitions can aid diagnosis of cerebral/cortical visual impairment in children.

A CHLA study explores the role of the extracellular matrix in difficult-to-treat forms of Wilms tumor.

Jesse Berry, MD, shares how CHLA’s pioneering liquid biopsy is personalizing care for retinoblastoma.

A study co-led by CHLA is testing a unique intervention to address a diabetes technology disparity among Latinx youth.

A CHLA expert shares her experience of administering this gene therapy for Duchenne—and why comprehensive care is critical for patients.